Rare but there, neuroendocrine carcinoma of the cervix is an uncommon yet devastating disease. Through the grass-roots efforts of a large support network of patients and loved ones, awareness and funds have been raised in an attempt to improve survivorship and hope.
We aim to build upon their amazing efforts to (1) educate patients, caregivers, and the medical community about this rare disease, (2) form a cancer registry to understand the most effective existing treatments, (3) conduct meaningful research to better understand the biology of this cancer, and (4) ultimately perform clinical trials utilizing new and innovative treatments to improve survival.
- Professor, The University of Texas M. D. Anderson Cancer Center
Dr. Frumovitz is a Professor in Gynecologic Oncology at The University of Texas M.D.Anderson Cancer Center in Houston, TX. He completed his residency training at Columbia-Presbyterian Hospital in New York and fellowship at M.D.Anderson. He has been a faculty member there since completion of his training and currently serves as the fellowship program director in addition to his clinical and research activities. He has actively worked to conduct meaningful research in this rare disease, including initiation of a clinical trial. Additionally, he has been an integral member of the team who helped to make this website and associated research possible. Read more about this trial.
- Assistant Professor, Gynecologic Oncology
Dr.Jennifer Burzawa is an Assistant Professor in Gynecologic Oncology at The University of Texas M.D.Anderson Cancer Center in Houston, TX. She completed residency training at Baylor College of Medicine and fellowship at M.D.Anderson, where she now serves as a faculty member.
Dr.Burzawa joined the small cell/large cell neuroendocrine cervical cancer team in 2012. Since then, she has worked closely with Dr. Frumovitz, Naomi and other influential members to expand the project including this website as well as other research projects.
- Clinical Studies Coordinator
Naomi Gonzales joined the small cell/large cell neuroendocrine cervical cancer team in 2012 and serves as the Clinical Studies Coordinator for all research conducted at M.D.Anderson for the projects underway about neuroendocrine cervical cancer. She has been an invaluable asset to the team.
Small Beginnings: The story of the
Small and Large Cell Sisterhood
The Small & Large Cell Sisterhood began with a young woman, Meredith Wright, who was diagnosed with small cell cervical cancer in 2005. Throughout her journey, she reached out to others via the internet. Even after her death, her legacy continued on as women newly diagnosed with small and large cell cervical cancer found her writings. These women were inspired to start a Facebook page in 2010 which continues offering support to women with neuroendocrine cervical cancer and their supporters. Within this group, modest fundraising efforts eventually blossomed into large scale, ongoing research for a cure to this disease.